TNG Pharmaceuticals
Latest round
- Series A
Last raised
- Feb 2014
Total raised
- $4.6M
Investors
- 7
About TNG Pharmaceuticals
TNG Pharmaceuticals, Inc. is the US-based company and operates as a developer of patented vaccine that reduces the horn fly population.
Who invested in TNG Pharmaceuticals
7 investors across 1 round
See all investors in TNG Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Feb 6, 2014
Amount
$4.6M
Investors
Questions about TNG Pharmaceuticals
Who invested in TNG Pharmaceuticals?
TNG Pharmaceuticals has 7 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has TNG Pharmaceuticals raised?
TNG Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did TNG Pharmaceuticals last raise money?
TNG Pharmaceuticals's most recent round on record is a Series A, in Feb 2014.
What does TNG Pharmaceuticals do?
TNG Pharmaceuticals is a pharmaceuticals company.
Where is TNG Pharmaceuticals headquartered?
TNG Pharmaceuticals is headquartered in Louisville, US.
Which VCs invest in companies like TNG Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at TNG Pharmaceuticals's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like TNG Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.